Pfizer (PFE) Construction in Progress (2009 - 2013)

Pfizer (PFE) has 5 years of Construction in Progress data on file, last reported at $1.1 billion in Q4 2013.

• Construction in Progress for Q4 2013 came in at $1.1 billion, up 15.15% year-over-year; the trailing twelve-month figure through Dec 2013 was $1.1 billion (up 15.15% YoY), and the FY2013 annual result was $1.1 billion, up 15.15% from the prior year.
• Construction in Progress advanced to $1.1 billion in Q4 2013 per PFE's latest filing, from $957.0 million in the prior quarter.
• Over five years, Construction in Progress peaked at $2.0 billion in Q4 2009 and troughed at $957.0 million in Q4 2012.
• A 5-year average of $1.3 billion and a median of $1.1 billion in 2013 frame the typical range for Construction in Progress.
• The sharpest annual moves came in 2010 and 2011: Construction in Progress sank 49.19% in 2010, then rose 29.53% in 2011.
• A 5-year view of Construction in Progress shows it stood at $2.0 billion in 2009, then sank by 49.19% to $999.0 million in 2010, then rose by 29.53% to $1.3 billion in 2011, then decreased by 26.04% to $957.0 million in 2012, then rose by 15.15% to $1.1 billion in 2013.
• Business Quant data shows PFE's Construction in Progress at $1.1 billion in Q4 2013, $957.0 million in Q4 2012, and $1.3 billion in Q4 2011.